RBF Capital’s Ventyx Biosciences VTYX Stock Holding History

RBF Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-72,490	Closed	-$83.4K	–	630
2025 Q1	$83.4K	Buy	+72,490	New	+$124K	0.01%	553

Other funds holding VTYX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

RBF Capital's VTYX Position: Q2 2025 in Review

RBF Capital sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 72,490 shares — an estimated $83.4K sold.

RBF Capital first reported a position in VTYX in Q1 2025 and held it in 1 quarter. The position peaked at $83.4K in Q1 2025. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

RBF Capital reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
RBF Capital sold 72,490 Ventyx Biosciences shares in Q2 2025, an estimated $83.4K.
RBF Capital first reported a position in Ventyx Biosciences in Q1 2025 and held it in 1 quarter.
RBF Capital's Ventyx Biosciences position peaked at $83.4K in Q1 2025.
114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on RBF Capital's 13F filing for Q2 2025, filed 14 Aug 2025.